190 related articles for article (PubMed ID: 21533280)
1. Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.
Zhou YH; Tang LG; Guo SL; Jin ZC; Wu MJ; Zang JJ; Xu JF; Wu CF; Qin YY; Cai Q; Gao QB; Zhang SS; Yu DH; He J
PLoS One; 2011 Apr; 6(4):e18788. PubMed ID: 21533280
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive agents for treating IgA nephropathy.
Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid therapy in IgA nephropathy.
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H;
J Am Soc Nephrol; 2012 Jun; 23(6):1108-16. PubMed ID: 22539830
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
Pozzi C; Andrulli S; Del Vecchio L; Melis P; Fogazzi GB; Altieri P; Ponticelli C; Locatelli F
J Am Soc Nephrol; 2004 Jan; 15(1):157-63. PubMed ID: 14694168
[TBL] [Abstract][Full Text] [Related]
7. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials.
Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
Nephrology (Carlton); 2004 Aug; 9(4):177-85. PubMed ID: 15363047
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials.
Zhang Z; Yang Y; Jiang SM; Li WG
BMC Nephrol; 2019 Aug; 20(1):333. PubMed ID: 31455248
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.
Hirano K; Kawamura T; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Matsushima M; Hanaoka K; Ogura M; Utsunomiya Y; Hosoya T
Clin Exp Nephrol; 2013 Aug; 17(4):555-62. PubMed ID: 23224025
[TBL] [Abstract][Full Text] [Related]
12. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Visciano B; Pani A; De Silvestri A; De Simone I; Del Vecchio L; Terraneo V; Furiani S; Santagostino G; Corghi E; Pozzi C
PLoS One; 2016; 11(7):e0158584. PubMed ID: 27416024
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
Nagasawa Y; Yamamoto R; Shinzawa M; Shoji T; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y
Clin Exp Nephrol; 2020 Oct; 24(10):927-934. PubMed ID: 32642919
[TBL] [Abstract][Full Text] [Related]
15. An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.
Strippoli GF; Manno C; Schena FP
Am J Kidney Dis; 2003 Jun; 41(6):1129-39. PubMed ID: 12776264
[TBL] [Abstract][Full Text] [Related]
16. The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up.
Tian L; Shao X; Xie Y; Wang L; Wang Q; Che X; Ni Z; Mou S
Expert Opin Pharmacother; 2015 Jun; 16(8):1137-47. PubMed ID: 25892092
[TBL] [Abstract][Full Text] [Related]
17. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive agents for treating IgA nephropathy.
Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
Cochrane Database Syst Rev; 2003; (4):CD003965. PubMed ID: 14584001
[TBL] [Abstract][Full Text] [Related]
19. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
[TBL] [Abstract][Full Text] [Related]
20. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
